Milad Enferadi

Dr. Milad Enferadi is an Associate Research Scientist in the Department of Radiology & Biomedical Imaging at Yale School of Medicine. He holds a CAMPEP-accredited Certificate in Medical Physics from Harvard Medical School and has extensive experience in nuclear medicine, radiation physics, and nanomedicine. His research focuses on radioisotope production, radiopharmaceutical synthesis, and the application of advanced imaging techniques in cancer treatment and diagnosis. Dr. Enferadi has collaborated internationally, including at the Mayo Clinic Florida for clinical radioembolization dosimetry.

Dr. Enferadi’s academic background includes a PhD in Clinical Medical Sciences from Chang Gung University/Chang Gung Memorial Hospital and a PhD in Medical Physics from Iran University of Medical Sciences. He has held research positions at institutions such as Tehran University of Medical Sciences, Mayo Clinic, and the University Hospital Salzburg. His postdoctoral work at Yale University furthered his expertise in radiopharmaceuticals and medical imaging.

His research interests span health physics, in vivo dosimetry, nuclear medicine, and radiation oncology. He investigates the biological effects of radiation, the development of targeted radionuclide therapies, and the optimization of imaging technologies like PET/MR systems. Notably, he has explored the use of nanoparticles for radiosensitization in cancer treatments and the impact of sleep on radiation therapy efficacy.

Dr. Enferadi’s recent publications address topics such as quantitative PET/CT analysis for Hodgkin’s lymphoma, radiomics in breast cancer diagnosis, and the effects of magnetic fields on PET/MR imaging accuracy. His work emphasizes interdisciplinary approaches, combining medical physics, machine learning, and clinical applications to advance cancer treatment and diagnostics.

While specific grants or awards are not mentioned, his involvement in funded preclinical and clinical investigations at Yale highlights his contribution to translational research. His work often involves collaborations with international institutions, reflecting his global impact in the field. Dr. Enferadi is affiliated with the Yale PET Center, a leading facility for positron emission tomography research and clinical applications.